You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
魯抗醫藥(600789.SH)擬共同出資設立北方健康 持股4%
格隆匯 06-23 18:40

格隆匯6月23日丨魯抗醫藥(600789.SH)公佈,公司擬與山東新華製藥股份有限公司(以下簡稱“新華製藥”)及其他投資人共同出資成立“北方健康醫療大數據科技有限公司”(以下簡稱“北方健康”)。擬設立公司註冊資本為25億元人民幣。公司以貨幣認繳出資1億元,持股4%;新華製藥以貨幣認繳出資1億元,持股4%。由於公司與新華製藥同為華魯集團的控股子公司,本次交易構成關聯交易。

聯仁健康是健康醫療大數據領域的“國家隊”,大數據是未來各種產業的核心與大腦,設立北方健康,業務發展符合未來醫療大健康行業發展方向,且其股東方具有資本、資源、技術等優勢;北方健康作為健康醫療大數據產業集團,在實現山東省互聯互通的基礎上,逐步匯聚北方地區數億人口全生命週期的健康醫療大數據,範圍覆蓋長江以北13個省市,人口6億,有利於為公司產品研發、臨牀發展及電商業務等提供數據支撐。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account